DE602004009079D1 - Carbostyril-derivative zur beschleunigten speichelabsonderung - Google Patents

Carbostyril-derivative zur beschleunigten speichelabsonderung

Info

Publication number
DE602004009079D1
DE602004009079D1 DE602004009079T DE602004009079T DE602004009079D1 DE 602004009079 D1 DE602004009079 D1 DE 602004009079D1 DE 602004009079 T DE602004009079 T DE 602004009079T DE 602004009079 T DE602004009079 T DE 602004009079T DE 602004009079 D1 DE602004009079 D1 DE 602004009079D1
Authority
DE
Germany
Prior art keywords
spoken
specialty
accelerated
carbostyril
carbostyril derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004009079T
Other languages
English (en)
Other versions
DE602004009079T2 (de
Inventor
Hisashi Nagamoto
Masayuki Kohashi
Hiroshi Oka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
St Marianna University School of Medicine
Original Assignee
Otsuka Pharmaceutical Co Ltd
St Marianna University School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, St Marianna University School of Medicine filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE602004009079D1 publication Critical patent/DE602004009079D1/de
Application granted granted Critical
Publication of DE602004009079T2 publication Critical patent/DE602004009079T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
DE602004009079T 2003-07-30 2004-07-07 Carbostyril-derivative zur beschleunigten speichelabsonderung Active DE602004009079T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003282691 2003-07-30
JP2003282691 2003-07-30
JP2004021808 2004-01-29
JP2004021808 2004-01-29
PCT/JP2004/009992 WO2005011811A1 (en) 2003-07-30 2004-07-07 Carbostyril derivatives for accelerating salivation

Publications (2)

Publication Number Publication Date
DE602004009079D1 true DE602004009079D1 (de) 2007-10-31
DE602004009079T2 DE602004009079T2 (de) 2008-06-19

Family

ID=34117911

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009079T Active DE602004009079T2 (de) 2003-07-30 2004-07-07 Carbostyril-derivative zur beschleunigten speichelabsonderung

Country Status (10)

Country Link
US (1) US7879877B2 (de)
EP (1) EP1648563B1 (de)
JP (1) JP4394686B2 (de)
KR (1) KR100681360B1 (de)
CN (1) CN1859948B (de)
AT (1) ATE373502T1 (de)
DE (1) DE602004009079T2 (de)
HK (1) HK1097474A1 (de)
MY (1) MY142739A (de)
WO (1) WO2005011811A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006112961A2 (en) 2005-03-03 2006-10-26 Takasago International Corp. (Usa) Synergistic salivation components
CN101910116B (zh) 2008-01-18 2013-06-19 高砂香料工业株式会社 (2e，6z，8e)-n-异丁基-2，6，8-癸三烯酰胺(千日菊酰胺)的制备方法，以及包含该化合物的食品或饮料、香料或化妆品、或药物
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
WO2012114317A1 (en) 2011-02-25 2012-08-30 Nuformix Limited Novel rebamipide complexes and cocrystals
KR20140020289A (ko) 2011-03-24 2014-02-18 오츠카 세이야쿠 가부시키가이샤 레바미피드를 함유하는 구강 내 질환 치료용 의약 조성물
JP6710040B2 (ja) * 2015-11-06 2020-06-17 江崎グリコ株式会社 唾液分泌促進剤及び口腔用組成物
KR102190019B1 (ko) * 2018-10-23 2020-12-15 삼진제약주식회사 쇼그렌 증후군 예방 또는 치료용 조성물
EP4001434A3 (de) * 2020-11-18 2022-08-10 Korea Institute of Science and Technology Speichelbiomarker zur diagnose von xerostomie und seine verwendung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322425A (en) * 1980-03-14 1982-03-30 Otsuka Pharmaceutical Co., Ltd. Compositions for treating glaucoma
US4578381A (en) 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2812998B2 (ja) 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
KR0180248B1 (ko) 1991-06-07 1999-03-20 오오쓰까 아끼히꼬 항당뇨병약품
TW227558B (de) 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
AU672888B2 (en) 1993-03-18 1996-10-17 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives as matrix metalloproteinases inhibitors
JP2839827B2 (ja) 1993-10-05 1998-12-16 大塚製薬株式会社 ウレアーゼ阻害剤
CN1073418C (zh) 1993-10-21 2001-10-24 大塚制药株式会社 白细胞介素－8生成抑制剂
WO1996004911A1 (en) 1994-08-10 1996-02-22 Otsuka Pharmaceutical Co., Ltd. Method of preventing and treating ophthalmic inflammation and/or wound
JPH0971532A (ja) 1995-09-06 1997-03-18 Otsuka Pharmaceut Co Ltd 発癌抑制剤
AR004214A1 (es) 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
AR010771A1 (es) 1996-12-16 2000-07-12 Otsuka Pharma Co Ltd Inhibidor del complejo adp-ribosiltransferasa, agente para curar una enfermedad infecciosa y uso del mismo.
JPH11228413A (ja) 1998-02-20 1999-08-24 Otsuka Pharmaceut Co Ltd Ｎａｄアーゼ阻害剤

Also Published As

Publication number Publication date
MY142739A (en) 2010-12-31
WO2005011811A1 (en) 2005-02-10
EP1648563A1 (de) 2006-04-26
JP4394686B2 (ja) 2010-01-06
EP1648563B1 (de) 2007-09-19
ATE373502T1 (de) 2007-10-15
CN1859948A (zh) 2006-11-08
KR20060037408A (ko) 2006-05-03
US7879877B2 (en) 2011-02-01
US20070112026A1 (en) 2007-05-17
DE602004009079T2 (de) 2008-06-19
CN1859948B (zh) 2010-05-26
HK1097474A1 (en) 2007-06-29
KR100681360B1 (ko) 2007-02-12
JP2006528662A (ja) 2006-12-21

Similar Documents

Publication Publication Date Title
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation
BRPI0416143A (pt) sais farmaceuticamente aceitáveis de compostos de quinolinona tendo propriedades farmacêuticas aperfeiçoadas
SG166019A1 (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
NO20052739L (no) CCR5-antagonister som medikamenter
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
UA94901C2 (ru) Антибактериальные производные пиперидина
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
WO2006025070A3 (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
SE0400284D0 (sv) Novel compounds
MY143391A (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
BR0210028A (pt) Agentes antibacterianos
WO2006057922A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
ATE413388T1 (de) Muskarin antagonisten
TW200730176A (en) Formulations of quinolinones
NO20040881L (no) Orale antidiabetes midler.
SE0101932D0 (sv) Pharmaceutical combinations
NO20080033L (no) Kinolinderivater som NK3-antagonister
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
CA2437785A1 (en) Hiv inhibiting pyrazinone derivatives
AU2003223340A1 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
UA91549C2 (ru) Производные хинолина как антибактериальные агенты

Legal Events

Date Code Title Description
8364 No opposition during term of opposition